AU2002220968A1 - Process for the preparation of a fast dissolving dosage form - Google Patents

Process for the preparation of a fast dissolving dosage form

Info

Publication number
AU2002220968A1
AU2002220968A1 AU2002220968A AU2096802A AU2002220968A1 AU 2002220968 A1 AU2002220968 A1 AU 2002220968A1 AU 2002220968 A AU2002220968 A AU 2002220968A AU 2096802 A AU2096802 A AU 2096802A AU 2002220968 A1 AU2002220968 A1 AU 2002220968A1
Authority
AU
Australia
Prior art keywords
preparation
dosage form
fast dissolving
dissolving dosage
fast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002220968A
Other languages
English (en)
Inventor
Rajiv Malik
Deepak Murpani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2002220968A1 publication Critical patent/AU2002220968A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
AU2002220968A 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form Abandoned AU2002220968A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1170/DEL/2000 2000-12-15
IN1170DE2000 IN192750B (da) 2000-12-15 2000-12-15
PCT/IB2001/002354 WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Publications (1)

Publication Number Publication Date
AU2002220968A1 true AU2002220968A1 (en) 2002-06-24

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002220968A Abandoned AU2002220968A1 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Country Status (4)

Country Link
EP (1) EP1343481A4 (da)
AU (1) AU2002220968A1 (da)
IN (1) IN192750B (da)
WO (1) WO2002047607A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
KR100503949B1 (ko) * 2003-04-28 2005-07-26 주식회사유한양행 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
US20090110716A1 (en) 2007-10-31 2009-04-30 Frank Bunick Orally disintegrative dosage form
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8807979B2 (en) 2009-09-24 2014-08-19 Mcneil-Ppc, Inc. Machine for the manufacture of dosage forms utilizing radiofrequency energy
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (zh) * 2011-08-18 2013-01-09 海南良方医药有限公司 一种拉米夫定片剂组合物及其制备方法
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
RU2712267C2 (ru) 2014-01-10 2020-01-28 Джонсон энд Джонсон Консьюмер Инк. Способ изготовления таблеток с использованием радиочастотного излучения и частиц с поглощающим покрытием
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
MX2021009679A (es) 2019-02-22 2021-09-10 Catalent Uk Swindon Zydis Ltd Minimizacion de aglomeracion, aireacion y conservacion del revestimiento de composiciones farmaceuticas que comprenden ibuprofeno.
SG11202109022UA (en) 2019-02-22 2021-09-29 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
CA3178769A1 (en) 2020-05-18 2021-11-25 Jonas Savmarker New pharmaceutical composition for drug delivery
CA3238850A1 (en) 2021-11-25 2023-06-01 Jonas Savmarker Pharmaceutical composition comprising adrenaline

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1258428A (en) * 1984-06-28 1989-08-15 Nalinkant C. Damani Antacid composition
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5631023A (en) * 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
EP0893992B1 (en) * 1996-04-16 2004-03-03 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.

Also Published As

Publication number Publication date
IN192750B (da) 2004-05-15
EP1343481A2 (en) 2003-09-17
EP1343481A4 (en) 2004-03-17
WO2002047607A2 (en) 2002-06-20
WO2002047607A3 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
AU2002220968A1 (en) Process for the preparation of a fast dissolving dosage form
AU2001234993A1 (en) A process for forming a semiconductor structure
AU2002341241A1 (en) Process for the preparation of fast dissolving dosage form
HUP0402027A3 (en) Process for the preparation of a xantophyll
AU7466900A (en) A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2
AU2464401A (en) Process for the preparation of oligomeric compounds
AU2001267831A1 (en) DDS compound and process for the preparation thereof
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2002238421A1 (en) Process for the preparation of phenethylamine derivatives
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
HK1048112B (zh) 3-乙烯基-頭孢化合物的製備方法
AU2002229648A1 (en) A process for the preparation of citalopram
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU2001268641A1 (en) Cleaning tablets, and a process for the manufacture of the cleaning tablets
AU2001292578A1 (en) Pharmaceutical compounds
AU2001262575A1 (en) Process for the preparation of paper having a special appearance
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
AU3547001A (en) Method for producing pharmaceutical dosage forms
AU2677201A (en) A process for the preparation of substituted benzophenones
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
AU2002214977A1 (en) Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AUPQ916700A0 (en) A method of preparing a pharmaceutical composition